You searched for side effects - Page 95 of 311 - Medivizor
Navigation Menu

Deep dry needling improves leg stiffness in stroke survivors

Deep dry needling improves leg stiffness in stroke survivors

Posted by on May 16, 2020 in Stroke | 0 comments

In a nutshell This study investigated the effects of deep dry needling (DDN) in patients with stroke and leg spasticity (stiffness). Researchers suggested that DDN decreases leg muscle spasticity in stroke survivors. Some background Each year, 15 million people worldwide suffer a stroke. Stroke is a result of a decrease in blood flow to the...

Read More

LASER: is it effective for urinary incontinence and pelvic organ prolapse?

LASER:  is it effective for urinary incontinence and pelvic organ prolapse?

Posted by on May 16, 2020 in Urinary incontinence | 0 comments

In a nutshell This study reviewed the research available on the effects of laser therapy for urinary incontinence (UI) and pelvic organ prolapse (POP). The main finding was that that laser therapy improved UI, POP, or both. Some background UI (involuntary leakage of urine) can affect about 30% of women. POP happens when the muscles and tissues...

Read More

What is the effect of silodosin on sexual function in men with benign prostatic hyperplasia?

What is the effect of silodosin on sexual function in men with benign prostatic hyperplasia?

Posted by on May 16, 2020 in Benign prostatic hyperplasia | 0 comments

In a nutshell This study aimed to investigate the effects of silodosin (Rapaflo) on sexual function in men with benign prostatic hyperplasia (BPH). The main finding was that silodosin improved erectile function for most participants. Some background Sexual dysfunction is a common side effect of BPH (enlarged prostate gland). This may include...

Read More

Long-term outcomes for CAR-T cells treatment for relapsed or unresponsive chronic lymphocytic leukemia

Long-term outcomes for CAR-T cells treatment for relapsed or unresponsive chronic lymphocytic leukemia

Posted by on May 16, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the outcomes of anti-CD19 chimeric antigen receptor T cells in patients with relapsed or refractory (unresponsive) chronic lymphocytic leukemia.  This study concluded that high-dose treatment may be more effective in these patients in the long term.   Some background Chimeric antigen...

Read More

Maintenance treatment impact on sleep-wake rhythms and cancer-related fatigue in children with acute lymphoblastic leukemia

Maintenance treatment impact on sleep-wake rhythms and cancer-related fatigue in children with acute lymphoblastic leukemia

Posted by on May 16, 2020 in Leukemia | 0 comments

In a nutshell This study aimed to investigate the impact of maintenance treatment on cancer-related fatigue and sleep-wake rhythms in pediatric patients with acute lymphoblastic leukemia.   This study concluded that sleep-wake rhythms are disturbed, physical activity levels lower and cancer-related fatigue levels higher...

Read More

How effective and safe is non-insulin drug evogliptin for patients with type 2 diabetes?

How effective and safe is non-insulin drug evogliptin for patients with type 2 diabetes?

Posted by on May 10, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study compared the effectiveness and safety of evogliptin (Suganon) to another non-insulin drug, linagliptin (Tradjenta), in patients with type 2 diabetes (T2D). The results showed that evogliptin was as safe and effective at reducing patients’ blood glucose levels as linagliptin. Some background Several treatment options...

Read More

Which low-intensity chemotherapy is most effective for patients with classical Hodgkin lymphoma receiving stem cell transplantation?

Which low-intensity chemotherapy is most effective for patients with classical Hodgkin lymphoma receiving stem cell transplantation?

Posted by on May 10, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This study compared the effectiveness of three low-intensity chemotherapy combinations to treat patients with classical Hodgkin lymphoma (HL) following stem cell transplantation (SCT). There were no significant differences between the three chemotherapy types in terms of patients’ survival and relapse. Some background...

Read More

Overview of follicular lymphoma treatment

Overview of follicular lymphoma treatment

Posted by on May 10, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This review discussed the treatment of follicular lymphoma (FL).  Some background FL is a cancer of B cells, a type of white blood cell. FL is one of the most common forms of lymphoma. FL is a slow-growing, painless (indolent) cancer that does not always need immediate treatment. Over time, FL can grow more quickly or transform...

Read More

Treating patients with high risk acute promyelocytic leukemia (APL) with ATRA, arsenic trioxide and gemtuzumab ozogamicin

Posted by on May 10, 2020 in Leukemia | 0 comments

In a nutshell The study evaluated the effectiveness and safety of combing all-trans retinoic acid (ATRA; Vesanoid), arsenic trioxide (ATO; Trisenox), and gemtuzumab ozogamicin (GO; Milotarg) in treating patients with high risk (HR) acute promyelocytic leukemia (APL). The authors found that the combination therapy was effective and well...

Read More

What are the treatment options for patients with Hodgkin lymphoma who are 60 or older?

What are the treatment options for patients with Hodgkin lymphoma who are 60 or older?

Posted by on May 10, 2020 in Hodgkin's lymphoma | 0 comments

In a nutshell This article reviewed treatment options for patients with Hodgkin lymphoma (HL), aged 60 or older. Some background Approximately 20% of patients with HL are aged 60 or older. Treatment options for older patients with HL differ from patients under 60. This is because older patients are more often diagnosed with advanced HL...

Read More

Which chemotherapy combination causes less kidney damage to patients with non-Hodgkin lymphoma?

Which chemotherapy combination causes less kidney damage to patients with non-Hodgkin lymphoma?

Posted by on May 9, 2020 in Non-Hodgkin lymphoma | 0 comments

In a nutshell This study compared two chemotherapy combinations – R-DHAP and R-DHAOx – to see which caused less kidney damage in patients with non-Hodgkin lymphoma (NHL). The results showed that fewer patients receiving R-DHAOx developed poor kidney function than patients receiving R-DHAP. Some background Combinations of chemotherapy...

Read More

Can novel non-insulin therapies for patients with type 2 diabetes prevent heart disease?

Can novel non-insulin therapies for patients with type 2 diabetes prevent heart disease?

Posted by on May 9, 2020 in Diabetes mellitus | 0 comments

In a nutshell This study examined how frequent heart disease is among patients taking different non-insulin medications for type 2 diabetes (T2D). The results showed that certain medications significantly reduced the risk of patients developing heart disease and other complications of T2D. Some background Heart disease is a serious...

Read More